Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Thoracic Malignancies
Would the presence of an SVC stent affect your decision to offer BID vs once-daily chemoradiation for SCLC?
Does the presence of an SVC stent preclude 60/40 or other BID dose escalation for SCLC?
Answer from: Radiation Oncologist at Community Practice
There is no evidence to guide the practice one way or the other. From a biological standard point, it should not.
Sign in or Register to read more
30024
Related Questions
In ES-SCLC presenting with extensive brain metastases, how do you time whole brain radiation after the first cycle of chemotherapy has already been delivered?
Do you offer adjuvant durvalumab for stage I small cell lung cancer following SBRT or surgery?
Would you give lung SBRT to a patient with bullous pemphigoid on the chest and torso?
How do you assess whether a patient will be a good DIBH candidate for lung or abdomen treatments?
Would you offer empiric lung SBRT for two growing FDG-avid lung lesions in a patient with severe COPD on oxygen?
Is there a concern for using FFF beams in single isocenter multi target lung SBRT?
How do you talk with your patients regarding radiographic expectations on surveillance CT after lung SBRT?
how do you manage atypical adenomatous hyperplasia (AAH) at the margin for 2 sites of the same lobe, in a patient with multiple GGO's s/p wedge resection?
Do you restrict the dose rate during treatment delivery to a pacemaker in addition to limiting the Dmax?
For NSCLC patients treated with neoadjuvant chemoimmunotherapy and surgery with ypN2 disease, what factors would cause you to recommend PORT?